1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Kidney conditions
  5. Acute kidney injury

RenalSense Clarity RMS for acute kidney injury

Medtech innovation briefing [MIB256] Published: 06 April 2021

  • Overview
  • Summary
  • The technology
  • Regulatory information
  • Equality considerations
  • Clinical and technical evidence
  • Expert comments
  • Expert commentators
  • Development of this briefing
Download (PDF)

Advice

  • Next

Regulatory information

Regulatory information

RenalSense Clarity RMS is a CE-marked class 2a medical device.


  • Next